ESMO 2025: Immunotherapy after surgery shows promise in treating rare, aggressive skin cancer
A drug that harnesses the immune system to attack cancer cells has proved successful in…
A drug that harnesses the immune system to attack cancer cells has proved successful in…
A new, highly potent class of immunotherapeutics with unique Velcro-like binding properties can kill diverse…
In a new study published in Nature Communications, researchers at Karolinska Institutet and Queen Mary…
A sneak preview podcast of what to expect from the AGITG’s 2025 ASM!
People with more than one tattoo session may have a decreased risk of the skin…
How fat is distributed in people’s bodies could make a difference to their risk of…
The number of cancer rehabilitation programmes in Australia has more than doubled in the past…
Previously, the primary endpoint results of the NRG-LU005 study assessing the addition of the immunotherapy…
Removing lymph nodes during cancer surgery has saved countless lives in many tumour types. Yet recent research…
Radical prostatectomy (RP) remains a cornerstone treatment for localised prostate cancer, with more than 85%…